The clinical development of Advanced Therapy Medicinal Products (ATMPs) presents unique challenges. Whilst they may be transformative for patients, their optimal design, clinical delivery and long-term benefits are still to be determined. Innovative clinical trial design allows for trials to be adapted to emerging clinical data and manufacturing innovation resulting in potential improved speed and efficiency of trials, shortened time to market and ultimately accelerating patient access to treatments.

Also central to this work is the ability to assess and improve institutional readiness (IR) of hospitals and clinics to implement this innovation in clinical delivery of ATMPs as more of these new therapies enter clinical studies and reach market authorisation.

Such innovation requires close collaboration between developers, regulators, payers and clinical trial sites to ensure evidence requirements are met. The Cell and Gene Therapy Catapult, Association of British Pharmaceutical Industry (ABPI) and UK BioIndustry Association (BIA) jointly invite you to explore the interfaces in these collaborations and to specifically identify and discuss areas for improvements and key recommendations.

You can view the full agenda below.

You can view highlights from last year's event here.

This event is held in partnership with the Advanced Therapy Treatment Centre (ATTC) network, and London Advanced Therapies (LAT).

Please RSVP by registering above. We look forward to welcoming you to the meeting.

13:00-13:05, Welcome and introduction
13.05-13.15, Direction of travel for the ATTC network
13.15-13.30, Institutional Readiness for ATMP Adoption
13.30-13.45, Patient focus within the ATMP landscape
13.45-14.00, Ramping up to a national ATMP training programme
14.00-14.15, Update on the London Advanced Therapies programme
14.15-14.35, Making the UK attractive to run advanced therapy trials
14.35-14.45, Break
14.45-15.30, Panel discussion: Identifying solutions to overcoming clinical operations challenges arising from innovative clinical trials design
15.30-15.35, Break
15.35-16.25, Presentation and Panel discussion: Identifying innovative solutions to overcoming reimbursement challenges arising from advanced therapy clinical trials
16.25-16.30, Summary of outputs and close

Registrations are closed

Clinical Adoption Day 2020